Broken bones and joint replacements may someday heal faster, thanks to an unusual coating for medical implants under development at The Ohio State University. Researchers have found that bone cells grow and reproduce faster on a textured surface than they do on a smooth one—and they grow best when they can cling to a microscopic shag carpet made of tiny metal oxide wires.
The discovery of a gene's function in E. coli and other bacteria might lead to a probiotic to prevent the most common type of kidney stone, according to a Purdue University study. Human cells can't metabolize oxalate, an acidic chemical found in nearly all plants we eat, so any oxalate we absorb from food must be excreted from the body.
Fitness fanatics may soon be able to gauge if their hard work is paying off without the need for weighing scales thanks to a new device that can instantly tell if your body is burning fat. The portable, pocket-sized sensor, produced by a group of researchers in Japan, works by measuring increased levels of acetone on the breath.
ReVision Optics said it's raised $55 million from a consortium of investors and closed enrollment in a clinical trial of its Raindrop near vision inlay to treat presbyopia. The Lake Forest, Calif.-based company said all of its existing backers – Canaan Partners, ProQuest Investments, InterWest Partners and Domain Assoc. – were joined by new investors Johnson & Johnson Development Corp. and RusnanoMedInvest in the round.
Hansen Medical said it agreed to pay out $8.5 million in cash and stock to put to rest a shareholders' lawsuit filed over its 2009 restatement of revenues. The Mountain View, Calif.-based robotic surgery company said it agreed to pay $4.25 million in cash and another $4.5 million worth of its own stock to settle the lawsuit.
California-based Caymus Medical is looking to raise $10 million through sales of equity, according to an SEC filing submitted this week. Caymus has raised $3.9 million so far from 19 investors, according to the filing. Investors' names were not listed and the company didn't specify what it plans to do with the funds.
The University of Salford has carried out a systematic review of the literature to research the effectiveness of telehealth on clinical outcomes, cost effectiveness and patient experience. Telehealth allows patients to monitor long-term health conditions from home, reducing visits to a clinic or hospital.
Abbott Receives FDA Clearance for FreeStyle Precision Pro Blood Glucose and β–Ketone Monitoring SystemJuly 29, 2013 11:09 am | by Abbott | Comments
Abbott has announced that it has received U.S. FDA clearance for its FreeStyle Precision Pro Blood Glucose and β-Ketone Monitoring System, an advanced blood glucose monitoring system designed to address the key needs of hospital customers: high accuracy, efficient operation, dual-band wireless access to immediate test results, and helps in the reduction of the risk of test strip cross-contamination.
Robotic surgery device maker Intuitive Surgical Inc. is increasing its current share buyback by $779 million to approximately $1.5 billion and is entering an accelerated repurchase program with Goldman Sachs. President and CEO Dr. Gary Guthart said in a statement on Monday that the increase to its repurchase program and the accelerated buyback shows Intuitive Surgical's confidence in its da Vinci surgical system.
Researchers have generated functional hepatocytes from human stem cells, transplanted them into mice with acute liver injury, and shown the ability of these stem-cell derived human liver cells to function normally and increase survival of the treated animals.
Modern genomics has shown that just one mutation can be the difference between successfully treating a disease and having it spread rampantly throughout the body. Now, researchers have developed a new method that can look at a specific segment of DNA and pinpoint a single mutation, which could help diagnose and treat diseases such as cancer and tuberculosis.
Silk has walked straight off the runway and into the lab. According to a new study published in the Journal of Clinical Investigation, silk implants placed in the brain of laboratory animals and designed to release a specific chemical, adenosine, may help stop the progression of epilepsy.
Advanced Catheter Therapies, Inc. (ACT) has announced that the United States Patent and Trademark Office has issued U.S. Patent No. 8398589 B2 for its catheter technology. ACT is a research and development medical device company with a portfolio of innovative catheter technologies initially targeting vascular disease and restenosis.
InspireMD, Inc. (NYSE MKT: NSPR) ("Inspire" or the "Company"), a leader in embolic protection stents, said the first patient has been enrolled in the Master II IDE clinical trial to evaluate the safety and effectiveness of the MGuard™ Prime Embolic Protection Stent (EPS) in patients suffering from ST Elevation Myocardial Infarction (STEMI).
BioLineRx Announces CE-Mark Registration Trial Submission for Novel Treatment for Removal of Skin LesionsJuly 29, 2013 8:30 am | by Business Wire | Comments
BioLineRx (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, announced today that it has filed the necessary regulatory submissions to commence a pivotal, CE-Mark registration trial for BL-5010P - for the non-surgical removal of skin lesions - with the German Federal Institute for Drugs and Medical Devices (BfArM), as well as with the relevant ethics committees.